ModMed Receives Major Investment from Clearlake Capital
ModMed, a leading healthcare SaaS platform, has announced a significant majority growth investment from Clearlake Capital Group, as stated in a press release. The financial terms of the transaction were not disclosed.
ModMed specializes in AI-powered medical practice technology, offering solutions that enhance clinical and operational efficiency for providers across multiple specialties. The company's suite of products includes electronic health records, practice management, revenue cycle management, and patient engagement tools, all integrated with native AI features.
The investment from Clearlake Capital is expected to accelerate ModMed's growth and support its strategic initiatives. Joe Harpaz, Co-Chief Executive Officer at ModMed, expressed confidence that the partnership will strengthen the company's ability to deliver impactful solutions and maintain its position as a trusted technology partner for healthcare providers.
Clearlake Capital, known for its focus on technology and healthcare investments, sees long-term potential in ModMed's AI-enabled technology, which aims to simplify documentation and streamline workflows. The firm plans to leverage its operational improvement approach to drive further growth for ModMed's platform.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice Operations Oct 15 Study Tracks 270 Million Clinical AI Queries on OpenEvidence Oct 15 OpenAI Offers US University Labs Free GPT-Rosalind AccessLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
NAVER D2SF Backs ImpriMed in $10 Million Bridge Round
Healthleap Raises $38 Million for Hospital Risk Screening AI
Heidi Raises $340 Million for Health Care AI Expansion
Immunomatics Receives $100,000 Investment From GenDx Cofounder
Medsender Launches Agentic Referral Management for Specialty Practices
Daily AI Brief: the AI news that matters, in your inbox.